Detego Global
HORSHAM, UNITED KINGDOM / ACCESSWIRE / July 15, 2024 / Detego Global, a leader in digital forensics and cyber security, has been honoured with an esteemed Culture 100 award as one of the UK's greatest companies to work for. This recognition, presented by Hyer, celebrates organisations that have cultivated exceptional workplaces and prioritise employee well-being.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This year's Culture 100 awards employed a rigorous selection process, evaluating over 5,000 companies and interviewing more than 20,000 employees. Companies were assessed on employee satisfaction, work-life balance, career development opportunities, and overall workplace environment. Detego Global's inclusion in this elite group underscores its commitment to fostering a positive and inclusive culture where team members can thrive professionally and personally.
Andy Lister, Managing Director of Detego Global, expressed his views on the company's achievement: "At Detego Global, we believe that our success is intrinsically linked to the well-being and growth of our team. This award is a testament to our ongoing efforts to create an environment where innovation flourishes and each team member feels valued and supported. We're not just creating award-winning digital forensics tools; we're building careers and a community."
Detego Global stands at the forefront of hiring veterans from military and law enforcement sectors, recognising the unique perspectives and expertise these individuals bring to the table. This approach has proven invaluable in developing customer-centric solutions that Detego Global's clients in the military, law enforcement and corporate sectors trust to stay ahead of threats and mitigate potential risks.
The company's commitment to excellence extends beyond the workplace through its Corporate Social Responsibility (CSR) initiatives. Detego Global's ‘Progress Through Purpose' programme encompasses efforts in environmental conservation, support for veterans, empowerment of law enforcement teams, and community upliftment, demonstrating the company's dedication to making a positive impact beyond its core business activities.
For current employees, this Culture 100 award serves as validation of their collective efforts in creating a positive workplace culture. For potential recruits, it signals Detego Global's commitment to employee well-being and professional growth, making it an attractive destination for top talent in the tech industry.
As Detego Global continues to lead in digital forensics and cyber security, this award reinforces its position not just as a technology leader but also as an employer of choice in the UK's competitive tech landscape. It demonstrates that the company can excel in both its field and in creating a purpose-driven work environment that attracts and retains top talent keen to make a positive impact on society.
About Detego Global
Detego Global is a pioneering force in digital forensics and cyber security, providing cutting-edge solutions to law enforcement, government agencies, and corporate clients worldwide. With a commitment to innovation, social responsibility and employee well-being, Detego Global continues to set the standard for excellence in the industry while driving positive social change.
Contact Information
Company: Detego Global
Contact Person: Buddhika Karunasekara (Director of Marketing)
Phone Number: +44 (0) 7889 227 428
Release Date: 15 July 2024
SOURCE: Detego Global
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom